BioSpace News Archive

MR Solutions has installed the first 7T PET/MR preclinical imaging system in Israel.

Pinpoint Scientific is pleased to announce it has secured further investment into the business, to aid the development of its ImpactAir® range of environmental monitoring solutions.

Adamis Pharmaceuticals Corporation today announced that after the close of U.S. markets on November 22nd, it received a Complete Response Letter from the U.S. Food and Drug Administration regarding its New Drug Application for Adamis’ ZIMHI™ high-dose naloxone injection product for the treatment of opioid overdose.

Surface Oncology announced it has secured a debt financing facility for up to $25 million from K2 HealthVentures, a healthcare-focused specialty finance company.

Tyme Technologies, Inc., an emerging biotechnology company developing cancer metabolism-based therapies, announced it will ring the Nasdaq Opening Bell on Wednesday, November 27, to honor the many stakeholders who are committed to finding a cure for patients with pancreatic cancer during Pancreatic Cancer Awareness Month.

La Jolla Pharmaceutical Company, a leader in the discovery, development and commercialization of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases, announced that it will reassess continued development of LJPC-401 based on recent mixed clinical results.

Medexus Pharmaceuticals Inc. announced that it plans to host a conference call at 8:00 AM Eastern Time on Monday, December 2, 2019 to discuss the Company’s financial results for the second quarter ended September 30, 2019, as well as the Company’s corporate progress and other developments.

Galapagos NV announces a share capital increase arising from warrant exercises.

iTeos Therapeutics SA announced that Michel Detheux, Ph.D., President and Chief Executive Officer, will present at the upcoming Piper Jaffray 31st Annual Healthcare Conference on Tuesday, December 3, 2019 at 10:50 a.m.

On track to report topline results for TRILOGY 1 in December 2019 and TRILOGY 2 in January 2020